Long-term follow-up of deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of three cases

Surgical Neurology International

Volumn 5, Issue 9, 2014, Pages S416-S420

  Servello, Domenico ^a   Zekaj, Edvin ^a   Saleh, Christian ^a   Menghetti, Claudia ^a   Porta, Mauro ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Axial symptoms; deep brain stimulation; peripedunculopontine nucleus; progressive supranuclear palsy

Indexed keywords

EID: 84992268378     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.140208     Document Type: Article

References (33)

1. Albaugh DL, Shih YY. Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinsons Disease: What have we learned from neuroimaging studies?. Brain Connect 2014;4:1-14.
2. Brusa L, Iani C, Ceravolo R, Galati S, Moschella V, Marzetti F, et al. Implantation of the nucleus tegmenti pedunculopontini in a PSP-P patient: Safe procedure, modest benefits. Mov Disord 2009;24:2020-2.
3. Ferraye MU, Gerardin P, Debu B, Chabardes S, Fraix V, Seigneuret E, et al. Pedunculopontine nucleus stimulation induces monocular oscillopsia. J Neurol Neurosurg Psychiatry 2009;80:228-31.
4. Garcia-Rill E, Houser CR, Skinner RD, Smith W, Woodward DJ. Locomotion-inducing sites in the vicinity of the pedunculopontine nucleus. Brain Res Bull 1987;18:731-8.
5. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinsons disease. Exp Neurol 1999;158:135-42.
6. Hardman CD, Halliday GM. The external globus pallidus in patients with Parkinsons disease and progressive supranuclear palsy. Mov Disord 1999;14:626-33.
7. Hazrati LN, Wong JC, Hamani C, Lozano AM, Poon YY, Dostrovsky JO, et al. Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation. Mov Disord 2012;27:1304-7.
8. Kojima J, Yamaji Y, Matsumura M, Nambu A, Inase M, Tokuno H, et al. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci Lett 1997;226:111-4.
9. Lang AE. Treatment of progressive supranuclear palsy and corticobasal degeneration. Mov Disord 2005;20 Suppl 12:S83-91.
10. Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, et al. Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis. Alzheimers Dement 2010;6:70-4.
11. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
12. Mazzone P, Scarnati E, Garcia-Rill E. Commentary: The pedunculopontine nucleus: Clinical experience, basic questions and future directions. J Neural Transm 2011;118:1391-6.
13. Mazzone P, Sposato S, Insola A, Scarnati E. The deep brain stimulation of the pedunculopontine tegmental nucleus: Towards a new stereotactic neurosurgery. J Neural Transm 2011;118:1431-51.
14. Mazzone P, Sposato S, Insola A, Scarnati E. The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery 2013;73:894-906.
15. Mazzone P, Lozano A, Stanzione P, Galati S, Scarnati E, Peppe A, et al. Implantation of human pedunculopontine nucleus: A safe and clinically relevant target in Parkinsons disease. Neuroreport 2005;16:1877-81.
16. Mazzone P, Insola A, Sposato S, Scarnati E. The deep brain stimulation of the pedunculopontine tegmental nucleus. Neuromodulation 2009;12:191-204.
17. Moro E, Hamani C, Poon YY, Al-Khairallah T, Dostrovsky JO, Hutchison WD, et al. Unilateral pedunculopontine stimulation improves falls in Parkinsons disease. Brain 2010;133:215-24.
18. Muller J, Wenning GK, Wissel J, Seppi K, Poewe W. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 2002;249:300-4.
19. Munro-Davies L, Winter J, Aziz TZ, Stein J. Kainate acid lesions of the pedunculopontine region in the normal behaving primate. Mov Disord 2001;16:150-1.
20. Nandi D, Jenkinson N, Stein J, Aziz T. The pedunculopontine nucleus in Parkinsons disease: Primate studies. Br J Neurosurg 2008;22 Suppl 1:S4-8.
21. Newman GC. Treatment of progressive supranuclear palsy with tricyclic antidepressants. Neurology 1985;35:1189-93.
22. Ostrem JL, Christine CW, Glass GA, Schrock LE, Starr PA. Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder. Stereotact Funct Neurosurg 2010;88:51-5.
23. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinsons disease. Brain 2000;123:1767-83.
24. Piccione F, Mancini E, Tonin P, Bizzarini M. Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: Report of two cases. Arch Phys Med Rehabil 1997;78:525-9.
25. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinsons disease. Neuroreport 2005;16:1883-7.
26. Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy: A survey of the disease course. Neurology 1998;50:1637-47.
27. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-59.
28. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinsons disease. Brain 2007;130:1596-607.
29. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardsons syndrome and PSP-parkinsonism. Brain 2005;128:1247-58.
30. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ. Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22:2235-41.
31. Yeh IJ, Tsang EW, Hamani C, Moro E, Mazzella F, Poon YY, et al. Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord 2010;25:2076-83.
32. Zrinzo L, Zrinzo LV, Massey LA, Thornton J, Parkes HG, White M, et al. Targeting of the pedunculopontine nucleus by an MRI-guided approach: A cadaver study. J Neural Transm 2011;118:1487-95.
33. Zrinzo L, Zrinzo LV, Hariz M. The pedunculopontine and peripeduncular nuclei: A tale of two structures. Brain 2007;130:e73.